No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Trinity Biotech Secures Funding for Glucose Monitoring Tech
Trinity Biotech Announces Additional $4M Funding
Trinity Biotech | 6-K: Report of foreign private issuer (related to financial reporting)
Home Healthcare Inflation Is Stubbornly High -- WSJ
Trinity Biotech's Latest CGM Trial Sets New Benchmark For Accuracy, Reliability, And User Experience
Express News | Trinity Biotech PLC - to Begin Further Pre-Pivotal Trials for Glucose Monitoring System in Q1 2025